Conor McNamara
Stock Analyst at RBC Capital
(0.84)
# 3,801
Out of 4,902 analysts
124
Total ratings
23.08%
Success rate
-18.92%
Average return
Main Sectors:
Stocks Rated by Conor McNamara
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TECH Bio-Techne | Maintains: Sector Perform | $72 → $63 | $53.29 | +18.22% | 9 | May 8, 2025 | |
| HOLX Hologic | Maintains: Sector Perform | $75 → $70 | $64.02 | +9.34% | 11 | May 2, 2025 | |
| BIO Bio-Rad Laboratories | Maintains: Outperform | $409 → $392 | $249.65 | +57.02% | 11 | May 2, 2025 | |
| BIO.B Bio-Rad Laboratories | Maintains: Outperform | $409 → $392 | $250.66 | +56.39% | 11 | May 2, 2025 | |
| RGEN Repligen | Maintains: Outperform | $202 → $189 | $124.04 | +52.37% | 11 | Apr 30, 2025 | |
| AVTR Avantor | Maintains: Outperform | $24 → $20 | $13.29 | +50.49% | 7 | Apr 28, 2025 | |
| TMO Thermo Fisher Scientific | Maintains: Outperform | $651 → $637 | $424.98 | +49.89% | 14 | Apr 24, 2025 | |
| DHR Danaher | Reiterates: Outperform | $250 | $194.79 | +28.34% | 10 | Apr 23, 2025 | |
| ILMN Illumina | Maintains: Outperform | $128 → $112 | $97.93 | +14.37% | 15 | Apr 8, 2025 | |
| OABI OmniAb | Maintains: Outperform | $7 → $4 | $1.96 | +104.08% | 3 | Mar 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $251 | $143.38 | +75.06% | 1 | Mar 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $64 → $61 | $26.68 | +128.64% | 11 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $17 → $13 | $2.51 | +417.93% | 6 | Nov 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $8 → $7 | $3.75 | +86.67% | 4 | Aug 7, 2024 |
Bio-Techne
May 8, 2025
Maintains: Sector Perform
Price Target: $72 → $63
Current: $53.29
Upside: +18.22%
Hologic
May 2, 2025
Maintains: Sector Perform
Price Target: $75 → $70
Current: $64.02
Upside: +9.34%
Bio-Rad Laboratories
May 2, 2025
Maintains: Outperform
Price Target: $409 → $392
Current: $249.65
Upside: +57.02%
Bio-Rad Laboratories
May 2, 2025
Maintains: Outperform
Price Target: $409 → $392
Current: $250.66
Upside: +56.39%
Repligen
Apr 30, 2025
Maintains: Outperform
Price Target: $202 → $189
Current: $124.04
Upside: +52.37%
Avantor
Apr 28, 2025
Maintains: Outperform
Price Target: $24 → $20
Current: $13.29
Upside: +50.49%
Thermo Fisher Scientific
Apr 24, 2025
Maintains: Outperform
Price Target: $651 → $637
Current: $424.98
Upside: +49.89%
Danaher
Apr 23, 2025
Reiterates: Outperform
Price Target: $250
Current: $194.79
Upside: +28.34%
Illumina
Apr 8, 2025
Maintains: Outperform
Price Target: $128 → $112
Current: $97.93
Upside: +14.37%
OmniAb
Mar 27, 2025
Maintains: Outperform
Price Target: $7 → $4
Current: $1.96
Upside: +104.08%
Mar 13, 2025
Initiates: Outperform
Price Target: $251
Current: $143.38
Upside: +75.06%
Feb 13, 2025
Maintains: Outperform
Price Target: $64 → $61
Current: $26.68
Upside: +128.64%
Nov 8, 2024
Maintains: Outperform
Price Target: $17 → $13
Current: $2.51
Upside: +417.93%
Aug 7, 2024
Maintains: Outperform
Price Target: $8 → $7
Current: $3.75
Upside: +86.67%